Name: Grazille Mangion
Company: Siegfried
Company Overview:
Siegfried is a prominent pharmaceutical manufacturing company headquartered in Zofingen, Aargau, Switzerland. Established in 1873, Siegfried has over 150 years of experience in producing active pharmaceutical ingredients (APIs), intermediates, and controlled substances. The company also specializes in the development and production of finished dosage forms, including sterile fillings.
Key Highlights:
- Employees: Approximately 3600 employees
- Global Presence: Operations in Switzerland, Germany, France, Spain, Malta, China, and the USA
- Specialties: Formulation Development, Analytical Development, Solid Dosage Forms, Parenterals, Ophthalmics, Sterile Filling, and Spray Drying.
Recent Achievements:
- Awarded EcoVadis Gold Medal for sustainability and corporate social responsibility.
- EGS Beteiligungen AG increased its shareholding in Siegfried to 7.2% registered shares.
Role and Professional Background:
Details specific to Grazille Mangion’s role at Siegfried are notably absent from the provided data. This might imply a non-public-facing or more background-oriented position. To gather actionable insights, connecting directly with Siegfried through professional networking platforms like LinkedIn or company-specific contact points is recommended.
Relevant Context and Key Connections at Siegfried:
- Matteo Mangion: Identified as an Apprentice Lab Analyst at Siegfried.
- Luca Monasteri: Senior QC Analyst based in Malta, emphasizing expertise in the use of physical devices, HPLC, Assay Analysis, and related substances.
Company Updates and Industry Engagement:
Siegfried showcases significant activity in advancing pharmaceutical manufacturing:
- Opened a new state-of-the-art R&D Center in Evionnaz in October, employing over 100 specialists focused on drug substance development.
- Actively recruiting for Chemistry Lab Assistants to join their expanding R&D endeavors.
- Engaged in viral vector production through DINAMIQS' new cGMP facility, indicating alignment with biotechnological advancements.
Strategic Initiatives and Industry Contributions:
- Siegfried's commitment to patient safety is highlighted by their participation in the World Health Organization's World Patient Safety Day.
- Continual focus on process optimization and industrialization through leadership roles, particularly in their St. Vulbas site.
Actionable Insights:
For a sales engagement, Siegfried represents a robust opportunity for collaboration, particularly around their pharmaceutical and biotechnological innovation efforts. Engaging with key decision-makers such as those involved in process optimization, R&D, and corporate social responsibility initiatives would be strategic. Direct connection with Grazille Mangion and leveraging mutual connections within the company could provide a more tailored approach to understanding Siegfried's specific needs and aligning on targeted solutions.
Further Steps:
To complete the profile and enhance the potential for a successful engagement, further research and direct communication within Siegfried might be necessary. Using the insights detailed here, targeted outreach could be directed towards individuals like Luca Monasteri or leveraging the information about Siegfried’s facilities and strategic initiatives.
